Biotechnology Articles page 10

Reuters - Best known for backing Web phone-calling leader Skype before it was bought by online auction house eBay Inc (EBAY.O: Quote , Profile , Research ), Index has also invested in a range of other up-and-coming technology and biotechnology firms. Zocco said it ...

Forbes - Funeral services were announced today for James LeVoy Sorenson, a biotechnology pioneer and entrepreneur whose medical inventions are used in nearly every hospital operating room and intensive care unit in the world. Sorenson passed away on Sunday ...

Forbes - Excellence in Alliances, examines how the business development executives at biotechnology and pharmaceutical companies view success in alliance creation, development and execution. This report captures metrics which rank and evaluate the importance ...

Forbes - Research and Markets (http://www.researchandmarkets.com/reports/c82930) has announced the addition of "Biotechnology in Flavour Production" to their offering. Biotechnology can deliver complex flavours both as fermentation products and single ...

Forbes - Cellestis is a listed Australian biotechnology company commercializing QuantiFERON(R) technology for diagnosing TB and other diseases worldwide. The Company operates through subsidiaries in the USA, Europe and Australia. For more information, visit ...

MSN MoneyCentral - It is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology. NASDAQ is the primary market for trading NASDAQ-listed stocks as well as ...

Seattle Times - Cell Therapeutics shares fell 17.4 percent Thursday after the Seattle biotechnology company said it had issued 6.85 million shares of stock to cancel $9.1 million of convertible debt due in June 2008. The stock closed down 29 cents at $1.38. The ...

Seattle Times - A former CellCyte executive said in a police report that she's being harassed by former colleagues who blame her as the source of media reports that led to the company's stock-market collapse. The Bothell biotechnology company's shares plummeted ...

Boston Globe - While DiMasi's proposal to boost the biotechnology and medical-device industry differs in some key respects from the one Patrick proposed last year, it does incorporate the major elements of the governor's initiative to build on the state's ...

Boston Globe - According to a regulatory filing yesterday, Icahn, 71, sold his stake in the Cambridge biotechnology company late last year after the company's stock price rose, easing speculation that he might try to mount a shareholder fight to force a sale or ...